TITLE

Duodenal--Jejunal Bypass Sleeve: A Totally Endoscopic Device for the Treatment of Morbid Obesity

PUB. DATE
December 2007
SOURCE
Surgical Innovation;Dec2007, Vol. 14 Issue 4, p275
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
28324186

 

Related Articles

  • Is Systemic Inflammation Not Involved in Endoscopic Duodenal-Jejunal Bypass Liner-Induced Diabetes Remission? Wu, Cheng-I; Lee, Wei-Jei; Chen, Chih-Yen // Obesity Surgery;Nov2014, Vol. 24 Issue 11, p2001 

    A letter to the editors is presented "Six months of treatment with the endoscopic duodenal-jejunal bypass liner does not lead to decreased systemic inflammation in obese patients with type 2 diabetes," by C. de Jonge and colleagues in the 2014 issue.

  • Endo Barrier trial to begin in US. Costa, Samantha; Kaplan, Lee M. // Endocrine Today;Mar2013, Vol. 11 Issue 3, p23 

    The article reports on the Endo Barrier endoscopic, drug-free device is believed to create a physical barrier when anchored in the duodenum to create a duodenal-jejunal bypass.

  • In obesity with type 2 diabetes, duodenal-jejunal bypass liners improved weight loss and HbA1c during treatment. Cheskin, Lawrence J.; Mullin, Gerard E. // Annals of Internal Medicine;2/17/2015, Vol. 162 Issue 4, pJC9 

    The article discusses the study "The effect of the endoscopic duodenal-jejunal bypass liner on obesity and type 2 diabetes mellitus, a multicenter randomized controlled trial" by P. Koehestanie and colleagues and published in a 2014 issue of the periodical "Annals of Surgery". Topics discussed...

  • NICE says trial coverage for bypass sleeve. McCARTY, MARK // Medical Device Daily;12/4/2013, Vol. 17 Issue 233, p9 

    The article focuses on the opinion given by the British National Institute for Health and Care Excellence (NICE) on the implantation of duodenal-jejunal bypass sleeve (DJBS) for management of obesity. Topics discussed include the call for clinicians to register their patients in the National...

  • The Duodenal-Jejunal Bypass Sleeve (EndoBarrier Gastrointestinal Liner) for Weight Loss and Treatment of Type II Diabetes. Patel, Shaneel; Mason, John; Hakim, Nadey // Indian Journal of Surgery;Aug2012, Vol. 74 Issue 4, p275 

    The author discusses the use of the duodenal-jejunal bypass sleeve technology to be used as a method of inducing weight loss especially in the case of obese patients with type 2 diabetes. Levels of excess weight loss are encouraging and suggest that the device may be useful in effectively...

  • The feasibility of delivering a duodenal-jejunal bypass liner (endobarrier) endoscopically with patients under conscious sedation. Koehestanie, Parviez; Betzel, Bark; Dogan, Kemal; Berends, Frits; Janssen, Ignace; Aarts, Edo; Groenen, Marcel; Wahab, Peter // Surgical Endoscopy;Jan2014, Vol. 28 Issue 1, p325 

    Background: The endoscopically placed duodenal-jejunal bypass liner (DJBL) or EndoBarrier gastrointestinal liner has been designed for the treatment of type 2 diabetes mellitus and simultaneous achievement of weight loss by obese patients. This study was performed to determine the safety,...

  • The Duodenal-Jejunal Bypass Liner for the Treatment of Type 2 Diabetes Mellitus and/or Obesity: a Systematic Review. Zechmeister-Koss, Ingrid; Huić, Mirjana; Fischer, Stefan // Obesity Surgery;Feb2014, Vol. 24 Issue 2, p310 

    This systematic literature review applies the GRADE approach to evaluate the efficacy and safety of the duodenal-jejunal bypass liner (DJBL) for the treatment of (a) patients with obesity ≥ grade II (with comorbidities) and (b) patients with type 2 diabetes mellitus + obesity ≥ grade...

  • Duodenal-jejunal bypass liner improved glycemic control, weight. Altersitz, Katrina; Costa, Samantha; Foster, Melissa // Endocrine Today;Oct2013, Vol. 11 Issue 10, p42 

    The article discusses the results of a study which showed the safety and effectiveness of duodenal-jejunal bypass liner device for the management of obese patients with type 2 diabetes, referencing a research by Julian Teare of the Imperial College of Healthcare National Health Service (NHS) Trust.

  • An Update on Less Invasive and Endoscopic Techniques Mimicking the Effect of Bariatric Surgery. Verdam, Froukje J.; Schouten, Ruben; Greve, Jan Willem; Koek, Ger H.; Bouvy, Nicole D. // Journal of Obesity;2012, Vol. 2012, p1 

    Obesity (BMI 30-35 kg/m2) and its associated disorders such as type 2 diabetes, nonalcoholic fatty liver disease, and cardiovascular disease have reached pandemic proportions worldwide. For the morbidly obese population (BMI 35-50 kg/m2), bariatric surgery has proven to be the most effective...

  • Chronic in-vivo experience with an endoscopically delivered and retrieved duodenal-jejunal bypass sleeve in a porcine model. Tarnoff, M.; Shikora, S.; Lembo, A.; Gersin, K. // Surgical Endoscopy;Apr2008, Vol. 22 Issue 4, p1023 

    The role of duodenal bypass as an underlying mechanism of action in gastric bypass surgery has received considerable attention. We report the initial feasibility study of a totally endoscopically delivered and retrieved duodenal–jejunal bypass sleeve in a chronic porcine model. The...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics